Inspec

Inspec EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Inspec (6656.T) as of Oct 21, 2026 is 15.49. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 22.59 — a change of -31.44% (lower).

EV/EBIT

15.49

YoY

-31.44%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Inspec is 2026 15.49 . EV/EBIT (Enterprise Value to EBIT) of Inspec was 2025 22.59 . It decreases by -31.44% lower compared to the previous year.

The Inspec EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
7.76 JPY
Jan 1, 2020
14.92 JPY
Jan 1, 2021
-8.84 JPY
Jan 1, 2022
129.94 JPY
Jan 1, 2023
18.00 JPY
Jan 1, 2024
-10.52 JPY
Jan 1, 2025
22.59 JPY
Jan 1, 2026
15.49 JPY
The Inspec EV/EBIT history
YEAREV/EBITYoY
15.49-31.44%
22.59-314.62%
-10.52-158.47%
18.00-86.15%
129.94-1,569.82%
-8.84-159.25%
14.92+92.37%
7.76-179.75%
-9.72-164.69%
15.03-112.01%
-125.13-644.81%
22.97-49.30%
45.30-1,941.52%
-2.46+67.35%
-1.47-105.60%
26.26-1,672.46%
-1.67+542.31%
-0.26-93.63%
-4.08-105.65%
72.23—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Inspec's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Inspec's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Inspec's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Inspec grows earnings faster than its peers.

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

EV/EBIT (Enterprise Value to EBIT) of Inspec is 15.49 in 2026.

EV/EBIT (Enterprise Value to EBIT) of Inspec changed from 22.59 to 15.49, representing a -31.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Inspec since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Inspec with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Inspec

All Key Metrics — Inspec